CERT
$25.82
Certara
$.19
.74%
CERT
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  $0.05
Revenue:  N/A
Thursday
Aug 5
4:15 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CERT reports earnings?
Beat
Meet
Miss

Where is CERT's stock price going from here?
Up
Flat
Down
Stock chart of CERT
Analysts
Summary of analysts' recommendations for CERT
Score
Grade
Pivots
Resistance
$29.74
$28.77
$27.20

$26.23

Support
$24.66
$23.69
$22.12
Tweet
Growth
Description
Certara Inc. provides medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Certara Inc. is based in NJ, United States.